Join our Mission to Protect Humankind!
Vaxcyte is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, which have serious and costly health consequences when left unchecked. Working to eradicate or treat bacterial infections such as invasive pneumococcal disease, Group A Strep, periodontitis and Shigella is just the beginning. Our path to success is clear and well-defined, and Vaxcyte is set up to go the distance.
WHAT we do is every bit as important as HOW we do it! Our work together is guided by four enduring core values:
*AIM HIGH: We embody our collectively audacious goal to courageously make the most complex biologics ever attempted to protect humankind.
*LEAD WITH HEART: Everyone leads at Vaxcyte with a kindness-first, inclusive approach to collaboration and vigorous debate that advances our business objectives.
*RETHINK CONVENTION: We bring creative and intellectual diversity to every facet of the work we do in order to innovate and re-innovate the way vaccines are delivered.
*MODEL EXCELLENCE: The magnitude of our challenge requires our shared commitment to demonstrating integrity, accountability, equality and clarity across communications and decision making.
- Oversee creation of feasible production schedules for DS & intermediates at our Lonza Visp CMO.
- Schedule delivery of Vaxcyte managed critical raw materials to Lonza Visp.
- Oversee the Lonza process for ordering commodity raw materials and consumables needed to support Vaxcyte production.
- Manage inventory of Vaxcyte owned materials in Europe.
- Ensure that our European partners have robust inventory management procedures.
- Oversee cycle counts and physical inventory counts.
- Define and monitor KPIs including delivery performance, yield, cycle time, reject rate and consumption rate.
- Lead cross functional Operations planning process including Lonza supply chain, Global Supply Chain, MSAT, Strategic Sourcing and QA.
- Manage our European third-party storage sites.
- Oversee shipments of product between our European production and storage sites.
- Own the shipping procedures for material coming out of our European mfg & storage sites.
- Proactively identify potential supply risks and initiate actions to mitigate.
- Oversee creation of supply dashboards to help organization understand overall status and risk areas.
Requirements
- B.S. / B.A. degree or Advanced Degree (preferred).
- 8 - 12 years’ experience working in pharmaceutical / biotech supply planning
- Strong Knowledge of GMPs.
- Strong Experience leading Cross-Functional teams.
- ·Strong experience managing direct reports.
- Strong experience working with CMOs and Suppliers of pharma materials.
- Strong experience with pharma cold chain logistics.
- Excellent analytic skills.
- Excellent communication skills.
- Fluent in English.
- Fluency in High German and/or Swiss German Highly preferred.
Reports to: Executive Director, Global Supply Chain
Location: Visp, Switzerland
Compensation:
The compensation package will be competitive and includes comprehensive benefits and an equity component.
Send resumes to:
Vaxcyte, Inc.
825 Industrial Road, Suite 300
San Carlos, CA 94070
We are an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability or veteran status.
What We Do
Vaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Vaxcyte’s lead candidate, VAX-24, is a 24-valent, broad-spectrum pneumococcal conjugate vaccine being developed for the prevention of invasive pneumococcal disease. Vaxcyte is re-engineering the way highly complex immunizations are made through modern synthetic techniques, including advanced chemistry and the XpressCFᵀᴹ cell-free protein synthesis platform, exclusively licensed from Sutro Biopharma, Inc. Unlike conventional cell-based approaches, the Company’s system for producing difficult-to-make proteins and antigens is intended to accelerate its ability to efficiently create and deliver high-fidelity vaccines with enhanced immunological benefits. Vaxcyte’s pipeline also includes VAX-XP, a PCV with an expanded breadth of coverage of greater than 30 strains; VAX-A1, a prophylactic vaccine candidate designed to prevent Group A Strep infections; and VAX-PG, a therapeutic vaccine candidate designed to slow or stop the progression of periodontal disease. Vaxcyte is driven to eradicate or treat invasive bacterial infections, which have serious and costly health consequences when left unchecked.
